Jones Cecilia

Chief Financial Officer

1 company

Average

Trades Analyzed

12M Win Rate

33.3%

Avg 3M Return

-3.5%

Avg 12M Return

-29.4%

Jones Cecilia is a Chief Financial Officer at AGIOS PHARMACEUTICALS, INC.. Recent SEC Form 4 filings include 0 buys and 10 sells.

Estimated insider holdings value: $1.4M based on current market prices.

Holdings by Company

AGIODec 30, 2025

Current Shares40.3K

Value$1.41M

Net Activity-19,514

Bought: 0Sold: 19.5K

Showing 9 filings

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Dec 30, 2025	AGIO Agios Pharmaceuticals, Inc.	Chief Financial Officer	Sale+OE	2,932	$27.09	$79,427.88	-7.3%	+8.3%	-
Sep 26, 2025	AGIO Agios Pharmaceuticals, Inc.	Chief Financial Officer	Sale+OE	3,651	$36.77	$134,247.27	-9.7%	-28.0%	-
Jun 24, 2025	AGIO Agios Pharmaceuticals, Inc.	Chief Financial Officer	Sale+OE	1,780	$33.54	$59,701.20	-5.6%	+14.3%	-
Mar 3, 2025	AGIO Agios Pharmaceuticals, Inc.	Chief Financial Officer	Sale+OE	2,275	$35.54	$80,853.50	-4.6%	-1.5%	-14.0%
Sep 26, 2024	AGIO Agios Pharmaceuticals, Inc.	Chief Financial Officer	Sale+OE	2,542	$49.03	$124,634.26	-11.2%	-28.5%	-19.0%
Mar 5, 2024	AGIO Agios Pharmaceuticals, Inc.	Chief Financial Officer	Sale+OE	672	$32.57	$21,887.04	-4.3%	+39.7%	+8.2%
Jan 24, 2024	AGIO Agios Pharmaceuticals, Inc.	Chief Financial Officer	Sale+OE	1,886	$21.64	$40,813.04	-12.6%	+47.9%	+64.5%
Sep 28, 2023	AGIO Agios Pharmaceuticals, Inc.	Chief Financial Officer	Sale+OE	2,179	$24.79	$54,017.41	-18.5%	-7.8%	+84.1%
Jun 30, 2023	AGIO Agios Pharmaceuticals, Inc.	Chief Financial Officer	Sale+OE	1,597	$28.36	$45,290.92	-29.7%	-12.5%	+52.3%